Peter W. Janes

4.3k total citations · 2 hit papers
42 papers, 3.4k citations indexed

About

Peter W. Janes is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Peter W. Janes has authored 42 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 19 papers in Oncology. Recurrent topics in Peter W. Janes's work include Axon Guidance and Neuronal Signaling (24 papers), HER2/EGFR in Cancer Research (16 papers) and Hippo pathway signaling and YAP/TAZ (13 papers). Peter W. Janes is often cited by papers focused on Axon Guidance and Neuronal Signaling (24 papers), HER2/EGFR in Cancer Research (16 papers) and Hippo pathway signaling and YAP/TAZ (13 papers). Peter W. Janes collaborates with scholars based in Australia, United States and Germany. Peter W. Janes's co-authors include Anthony I. Magee, Steven C. Ley, Martin Lackmann, Robert L. Sutherland, Roger J. Daly, Eva Nievergall, Panagiotis S. Kabouridis, Dimitar B. Nikolov, Anna DeFazio and Sabine Wimmer-Kleikamp and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Peter W. Janes

42 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aggregation of Lipid Rafts Accompanies Signaling via the T Cell Antigen Receptor

1999 705 citations Peter W. Janes, Steven C. Ley et al. The Journal of Cell Biology profile →
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects

2025 29 citations Zhipeng Cao, Laura D. Osellame et al. Journal of Biomedical Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter W. Janes Australia	27	2.1k	982	837	740	675	42	3.4k
Serge Roche France	37	3.1k 1.5×	348 0.4×	839 1.0×	1.0k 1.4×	509 0.8×	92	4.5k
Malin Jarvius Sweden	20	2.6k 1.2×	338 0.3×	652 0.8×	606 0.8×	392 0.6×	38	3.7k
Nina Marie Pedersen Norway	38	2.7k 1.2×	495 0.5×	1.5k 1.8×	882 1.2×	339 0.5×	75	4.6k
Kuo‐Sen Huang United States	26	2.0k 1.0×	634 0.6×	384 0.5×	359 0.5×	262 0.4×	45	3.1k
Sara Zanivan United Kingdom	27	2.7k 1.2×	453 0.5×	940 1.1×	703 0.9×	385 0.6×	83	4.1k
Karl‐Johan Leuchowius Sweden	11	2.3k 1.1×	293 0.3×	616 0.7×	394 0.5×	363 0.5×	15	3.2k
Jane McGlade Canada	23	5.0k 2.3×	723 0.7×	1.1k 1.3×	1.4k 1.9×	1.2k 1.8×	26	6.6k
Martin Lenter Germany	26	1.6k 0.8×	319 0.3×	407 0.5×	879 1.2×	599 0.9×	44	3.1k
Letizia Lanzetti Italy	26	2.2k 1.0×	242 0.2×	1.4k 1.7×	658 0.9×	362 0.5×	39	3.6k
Reiner Lammers Germany	39	4.6k 2.1×	399 0.4×	981 1.2×	1.1k 1.5×	1.3k 1.9×	75	6.1k

Countries citing papers authored by Peter W. Janes

Since Specialization

Citations

This map shows the geographic impact of Peter W. Janes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Janes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Janes more than expected).

Fields of papers citing papers by Peter W. Janes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Janes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Janes. The network helps show where Peter W. Janes may publish in the future.

Co-authorship network of co-authors of Peter W. Janes

This figure shows the co-authorship network connecting the top 25 collaborators of Peter W. Janes. A scholar is included among the top collaborators of Peter W. Janes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter W. Janes. Peter W. Janes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Zhipeng, et al.. (2025). Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects. Journal of Biomedical Science. 32(1). 7–7. 29 indexed citations breakdown →

Parakh, Sagun, Deliang Cao, Angela Rigopoulos, et al.. (2025). Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2. Molecular Cancer Therapeutics. 24(9). 1442–1452. 1 indexed citations

Parakh, Sagun, Deliang Cao, Angela Rigopoulos, et al.. (2025). Data from Characterization of mAb104, a mAb Targeting a Conformationally Exposed, Tumor-Specific Epitope of HER2. 1 indexed citations

Liang, Lung‐Yu, Niall D. Geoghegan, Michael J. Mlodzianoski, et al.. (2024). Co-clustering of EphB6 and ephrinB1 in trans restrains cancer cell invasion. Communications Biology. 7(1). 461–461. 1 indexed citations

Vail, Mary E., Rae H. Farnsworth, Linda Hii, et al.. (2023). Inhibition of EphA3 Expression in Tumour Stromal Cells Suppresses Tumour Growth and Progression. Cancers. 15(18). 4646–4646. 8 indexed citations

Seegar, T.C.M., Nayanendu Saha, Peter Meyer, et al.. (2017). Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10. Cell. 171(7). 1638–1648.e7. 123 indexed citations

Vail, Mary E., Carmel Murone, Linda Hii, et al.. (2014). Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment. Cancer Research. 74(16). 4470–4481. 67 indexed citations

Farnsworth, Rae H., Mary E. Vail, Caroline E. Gargett, et al.. (2014). Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth. PLoS ONE. 9(11). e112106–e112106. 18 indexed citations

Janes, Peter W., et al.. (2014). A Mathematical Model for Eph/Ephrin-Directed Segregation of Intermingled Cells. PLoS ONE. 9(12). e111803–e111803. 4 indexed citations

10.

Atapattu, Lakmali, Martin Lackmann, & Peter W. Janes. (2014). The role of proteases in regulating Eph/ephrin signaling. Cell Adhesion & Migration. 8(4). 294–307. 43 indexed citations

11.

Janes, Peter W., Eva Nievergall, & Martin Lackmann. (2012). Concepts and consequences of Eph receptor clustering. Seminars in Cell and Developmental Biology. 23(1). 43–50. 76 indexed citations

12.

Janes, Peter W., Lakmali Atapattu, Eva Nievergall, et al.. (2011). Eph receptor function is modulated by heterooligomerization of A and B type Eph receptors. The Journal of Cell Biology. 195(6). 1033–1045. 75 indexed citations

13.

Himanen, Juha P., Peter W. Janes, John R. Walker, et al.. (2010). Architecture of Eph receptor clusters. Proceedings of the National Academy of Sciences. 107(24). 10860–10865. 208 indexed citations

14.

Janes, Peter W., et al.. (2008). Eph/Ephrin Signalling and Function in Oncogenesis: Lessons from Embryonic Development. Current Cancer Drug Targets. 8(6). 473–489. 35 indexed citations

15.

Wimmer-Kleikamp, Sabine, Peter W. Janes, Anthony Squire, Philippe I. H. Bastiaens, & Martin Lackmann. (2004). Recruitment of Eph receptors into signaling clusters does not require ephrin contact. The Journal of Cell Biology. 164(5). 661–666. 107 indexed citations

16.

DeFazio, Anna, et al.. (2000). Expression of c-erbB receptors, heregulin and oestrogen receptor in human breast cell lines. International Journal of Cancer. 87(4). 487–498. 116 indexed citations

17.

Janes, Peter W., Steven C. Ley, Anthony I. Magee, & Panagiotis S. Kabouridis. (2000). The role of lipid rafts in T cell antigen receptor (TCR) signalling. Seminars in Immunology. 12(1). 23–34. 376 indexed citations

18.

Campbell, Douglas Houghton, et al.. (1998). Analysis of Grb7 Recruitment by Heregulin-activated erbB Receptors Reveals a Novel Target Selectivity for erbB3. Journal of Biological Chemistry. 273(13). 7717–7724. 81 indexed citations

19.

Janes, Peter W., et al.. (1998). Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Oncogene. 16(21). 2803–2813. 61 indexed citations

20.

Daly, Roger J., et al.. (1996). Cloning and Characterization of GRB14, a Novel Member of the GRB7 Gene Family. Journal of Biological Chemistry. 271(21). 12502–12510. 111 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact